12:00 AM
 | 
Dec 03, 2012
 |  BC Week In Review  |  Company News  |  Deals

Smith & Nephew, DFB deal

Smith & Nephew will acquire DFB's Healthpoint Biotherapeutics subsidiary for $782 million in cash. Smith & Nephew, which plans to integrate Healthpoint into its advanced wound management division, said Healthpoint will provide a range of marketed...

Read the full 160 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >